Wenwen Wang

2 months ago | pubs.acs.org | Peng R. Chen |Wenwen Wang |Ping Zhang |Yanyan Cui

2 months ago | dx.doi.org | Peng R. Chen |Wenwen Wang |Ping Zhang |Yanyan Cui

Jan 16, 2025 | mdpi.com | Juan Du |Yuan Wang |Shaohui Su |Wenwen Wang

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jun 22, 2024 | medium.com | Wenwen Wang

Readwise Reader is absolutely a game-changer for me as a reader and learner. One of its best features is the Feed. Here's how my email newsletter workflow changed, for the better.

May 9, 2024 | onlinelibrary.wiley.com | Liao Guan |Wenwen Wang |Xuefei Ji |Hongwei Cheng

Introduction Glioblastoma (GBM) is a frequent and invasive primary central nervous system (CNS) tumor in adults.1 According to the World Health Organization tumor classification, GBM is one of the highest graded gliomas featuring necrosis or microvascular hyperplasia.2 Multimodality treatments against GBM usually incorporate neurosurgery with subsequent radio- and/or chemo-therapies.